Kennedy PG: Cytokines in central nervous system trypanosomiasis: cause, effect or both? Trans R Soc Trop Med Hyg 2009, 103: 213–214. 10.1016/j.trstmh.2008.08.013
Article
CAS
PubMed
Google Scholar
Sternberg JM, Maclean L: A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence. Parasitology 2010, 137: 2007–2015. 10.1017/S0031182010000946
Article
PubMed
Google Scholar
Malvy D, Chappuis F: Sleeping sickness. Clin Microbiol Infect. 2011, 17: 986–995. 10.1111/j.1469-0691.2011.03536.x
Article
CAS
PubMed
Google Scholar
Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG: The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000–2009: the way forward. PLoS Negl Trop Dis 2011, 5: e1007. 10.1371/journal.pntd.0001007
Article
PubMed Central
PubMed
Google Scholar
Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Baudin E, Buard V, Kazadi-Kyanza S, et al.: Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 2009, 374: 56–64. 10.1016/S0140-6736(09)61117-X
Article
CAS
PubMed
Google Scholar
Simarro PP, Franco J, Diarra A, Postigo JA, Jannin J: Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 2012, 139: 842–846. 10.1017/S0031182012000169
Article
CAS
PubMed
Google Scholar
Kennedy PG: An alternative form of melarsoprol in sleeping sickness. Trends Parasitol 2012, 28: 307–310. 10.1016/j.pt.2012.05.003
Article
CAS
PubMed
Google Scholar
Burri C: Chemotherapy against human African trypanosomiasis: is there a road to success? Parasitology 2010, 137: 1987–1994. 10.1017/S0031182010001137
Article
CAS
PubMed
Google Scholar
Kuepfer I, Schmid C, Allan M, Edielu A, Haary EP, Kakembo A, Kibona S, Blum J, Burri C: Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage rhodesiense sleeping sickness. PLoS Negl Trop Dis 2012, 6: e1695. 10.1371/journal.pntd.0001695
Article
PubMed Central
CAS
PubMed
Google Scholar
WHO: Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1998, 881(I-VI):1–114.
Google Scholar
Kennedy PG: Diagnosing central nervous system trypanosomiasis: two stage or not to stage? Trans R Soc Trop Med Hyg 2008, 102: 306–307. 10.1016/j.trstmh.2007.11.011
Article
PubMed
Google Scholar
Simarro PP, Jannin J, Cattand P: Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 2008, 5: e55. 10.1371/journal.pmed.0050055
Article
PubMed Central
PubMed
Google Scholar
Amin DN, Ngoyi DM, Nhkwachi GM, Palomba M, Rottenberg M, Buscher P, Kristensson K, Masocha W: Identification of stage biomarkers for human African trypanosomiasis. Am J Trop Med Hyg 2010, 82: 983–990. 10.4269/ajtmh.2010.09-0770
Article
PubMed Central
CAS
PubMed
Google Scholar
Kennedy PG: The continuing problem of human African trypanosomiasis (sleeping sickness). Ann Neurol 2008, 64: 116–126. 10.1002/ana.21429
Article
PubMed
Google Scholar
Lejon V, Reiber H, Legros D, Dje N, Magnus E, Wouters I, Sindic CJ, Buscher P: Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. J Infect Dis 2003, 187: 1475–1483. 10.1086/374645
Article
PubMed
Google Scholar
Tiberti N, Hainard A, Lejon V, Robin X, Ngoyi DM, Turck N, Matovu E, Enyaru J, Ndung'u JM, Scherl A, et al.: Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis. Mol Cell Proteomics 2010, 9: 2783–2795. 10.1074/mcp.M110.001008
Article
PubMed Central
CAS
PubMed
Google Scholar
Hainard A, Tiberti N, Robin X, Ngoyi DM, Matovu E, Enyaru JC, Muller M, Turck N, Ndung'u JM, Lejon V, Sanchez JC: Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis. Trop Med Int Health 2011, 16: 119–126. 10.1111/j.1365-3156.2010.02642.x
Article
PubMed
Google Scholar
Hainard A, Tiberti N, Robin X, Lejon V, Ngoyi DM, Matovu E, Enyaru JC, Fouda C, Ndung'u JM, Lisacek F, et al.: A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Negl Trop Dis 2009, 3: e459. 10.1371/journal.pntd.0000459
Article
PubMed Central
PubMed
Google Scholar
Courtioux B, Pervieux L, Vatunga G, Marin B, Josenando T, Jauberteau-Marchan MO, Bouteille B, Bisser S: Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis. Trop Med Int Health 2009, 14: 529–534. 10.1111/j.1365-3156.2009.02263.x
Article
CAS
PubMed
Google Scholar
Bisser S, Lejon V, Preux PM, Bouteille B, Stanghellini A, Jauberteau MO, Buscher P, Dumas M: Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci 2002, 193: 127–135. 10.1016/S0022-510X(01)00655-4
Article
CAS
PubMed
Google Scholar
MacLean L, Odiit M, Sternberg JM: Nitric oxide and cytokine synthesis in human African trypanosomiasis. J Infect Dis 2001, 184: 1086–1090. 10.1086/323479
Article
CAS
PubMed
Google Scholar
Maclean L, Odiit M, Sternberg JM: Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients. Trans R Soc Trop Med Hyg 2006, 100: 270–275. 10.1016/j.trstmh.2005.03.013
Article
CAS
PubMed
Google Scholar
Tiberti N, Hainard A, Lejon V, Courtioux B, Matovu E, Enyaru JC, Robin X, Turck N, Kristensson K, Ngoyi DM, et al.: Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness. PLoS One 2012, 7: e40909. 10.1371/journal.pone.0040909
Article
PubMed Central
CAS
PubMed
Google Scholar
Miezan TW, Meda HA, Doua F, Dje NN, Lejon V, Buscher P: Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg 2000, 94: 293. 10.1016/S0035-9203(00)90327-4
Article
CAS
PubMed
Google Scholar
Cattand P, Miezan BT, de Raadt P: Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bull World Health Organ 1988, 66: 83–86.
PubMed Central
CAS
PubMed
Google Scholar
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M: pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011, 12: 77. 10.1186/1471-2105-12-77
Article
PubMed Central
PubMed
Google Scholar
MacLean LM, Odiit M, Chisi JE, Kennedy PG, Sternberg JM: Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense . PLoS Negl Trop Dis 2010, 4: e906. 10.1371/journal.pntd.0000906
Article
PubMed Central
PubMed
Google Scholar
Kennedy PG: Difficulties in diagnostic staging of human African trypanosomiasis. J Neuroparasitol 2011, 2: 1–3.
Article
CAS
Google Scholar
Kennedy PG: Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol 2006, 36: 505–512. 10.1016/j.ijpara.2006.01.012
Article
CAS
PubMed
Google Scholar
Gibson W: Will the real Trypanosoma brucei rhodesiense please step forward? Trends Parasitol 2002, 18: 486–490. 10.1016/S1471-4922(02)02390-5
Article
CAS
PubMed
Google Scholar
Lejon V, Legros D, Richer M, Ruiz JA, Jamonneau V, Truc P, Doua F, Dje N, N'Siesi FX, Bisser S, et al.: IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop Med Int Health 2002, 7: 685–692. 10.1046/j.1365-3156.2002.00917.x
Article
CAS
PubMed
Google Scholar
Lejon V, Roger I, Mumba Ngoyi D, Menten J, Robays J, N'Siesi FX, Bisser S, Boelaert M, Buscher P: Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis . Clin Infect Dis 2008, 47: 15–22. 10.1086/588668
Article
CAS
PubMed
Google Scholar
Rodgers J: Trypanosomiasis and the brain. Parasitology. 2010, 137: 1995–2006. 10.1017/S0031182009991806
Article
PubMed
Google Scholar
Lalor SJ, Segal BM: Lymphoid chemokines in the CNS. J Neuroimmunol 2010, 224: 56–61. 10.1016/j.jneuroim.2010.05.017
Article
PubMed Central
CAS
PubMed
Google Scholar
Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT: A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998, 391: 799–803. 10.1038/35876
Article
CAS
PubMed
Google Scholar
Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, et al.: Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129: 200–211.
Article
PubMed
Google Scholar
Rainey-Barger EK, Rumble JM, Lalor SJ, Esen N, Segal BM, Irani DN: The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system. Brain Behav Immun 2011, 25: 922–931. 10.1016/j.bbi.2010.10.002
Article
PubMed Central
CAS
PubMed
Google Scholar
Dziembowska M, Wlodarczyk J: MMP9: a novel function in synaptic plasticity. Int J Biochem Cell Biol 2012, 44: 709–713. 10.1016/j.biocel.2012.01.023
Article
CAS
PubMed
Google Scholar
Ramos-Fernandez M, Bellolio MF, Stead LG: Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 2011, 20: 47–54. 10.1016/j.jstrokecerebrovasdis.2009.10.008
Article
PubMed
Google Scholar
Unsal Y, Kivilcim G, Aysegul A, Arzu A, Esra G, Ercan D, Ayse S: Matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis. Pediatr Neurol 2012, 47: 171–176. 10.1016/j.pediatrneurol.2012.05.027
Article
PubMed
Google Scholar
Prato M, Giribaldi G: Matrix metalloproteinase-9 and haemozoin: wedding rings for human host and Plasmodium falciparum parasite in complicated malaria. J Trop Med 2011, 2011: 628435.
Article
PubMed Central
PubMed
Google Scholar
Szklarczyk A, Stins M, Milward EA, Ryu H, Fitzsimmons C, Sullivan D, Conant K: Glial activation and matrix metalloproteinase release in cerebral malaria. J Neurovirol 2007, 13: 2–10. 10.1080/13550280701258084
Article
CAS
PubMed
Google Scholar
Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM: Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 2006, 203: 1007–1019. 10.1084/jem.20051342
Article
PubMed Central
CAS
PubMed
Google Scholar
Robin X, Turck N, Hainard A, Lisacek F, Sanchez JC, Muller M: Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? Expert Rev Proteomics 2009, 6: 675–689. 10.1586/epr.09.83
Article
CAS
PubMed
Google Scholar
Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA: Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 1998, 273: 18288–18291. 10.1074/jbc.273.29.18288
Article
CAS
PubMed
Google Scholar
Amin DN, Rottenberg ME, Thomsen AR, Mumba D, Fenger C, Kristensson K, Buscher P, Finsen B, Masocha W: Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis 2009, 200: 1556–1565. 10.1086/644597
Article
CAS
PubMed
Google Scholar
Kristensson K, Nygard M, Bertini G, Bentivoglio M: African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions. Prog Neurobiol 2010, 91: 152–171. 10.1016/j.pneurobio.2009.12.001
Article
CAS
PubMed
Google Scholar
Kennedy PG: Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004, 113: 496–504.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hunter CA, Jennings FW, Kennedy PG, Murray M: Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei -infected mice. Lab Invest 1992, 67: 635–642.
CAS
PubMed
Google Scholar
Chappuis F, Loutan L, Simarro P, Lejon V, Buscher P: Options for field diagnosis of human African trypanosomiasis. Clin Microbiol Rev 2005, 18: 133–146. 10.1128/CMR.18.1.133-146.2005
Article
PubMed Central
PubMed
Google Scholar
Maclean L, Reiber H, Kennedy PG, Sternberg JM: Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response. PLoS Negl Trop Dis 2012, 6: e1857. 10.1371/journal.pntd.0001857
Article
PubMed Central
CAS
PubMed
Google Scholar
Ngotho M, Kagira JM, Jensen HE, Karanja SM, Farah IO, Hau J: Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys. Trop Med Int Health 2009, 14: 736–747. 10.1111/j.1365-3156.2009.02285.x
Article
CAS
PubMed
Google Scholar